Cargando…
1428. Lyme Disease Treatment in the United States: Prescribing Patterns from a Nationwide Commercial Insurance Database, 2016-2018
BACKGROUND: Lyme disease (LD) is the most common vector-borne disease in the United States and is a significant public health problem. The use of non-standard antibiotic treatment regimens for LD has been associated with adverse effects; however, the overall landscape of treatment has not been descr...
Autores principales: | Beeson, Amy M, Marx, Grace E, Schwartz, Amy M, Hinckley, Alison F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777307/ http://dx.doi.org/10.1093/ofid/ofaa439.1610 |
Ejemplares similares
-
1614. Single-Dose Doxycycline as Lyme Disease Post-Exposure Prophylaxis in a National Commercial Insurance Claims Database―the United States, 2014–2017
por: Marx, Grace E, et al.
Publicado: (2019) -
Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018
por: Schwartz, Amy M., et al.
Publicado: (2021) -
153. Utilization of Post-Exposure Prophylaxis to Prevent Lyme Disease in a Large US Healthcare Database
por: Marx, Grace E, et al.
Publicado: (2021) -
Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010–2018
por: Kugeler, Kiersten J., et al.
Publicado: (2021) -
Post-treatment Lyme borreliosis in context: Advancing the science and patient care
por: Marx, Grace E., et al.
Publicado: (2021)